If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
(1) The amounts reported in Rows 7, 9, and 11 include (a) 15,166,643 shares of Common Stock, (b) the Replacement 2020 Warrant exercisable for an indeterminate number of shares of Common Stock equal to approximately 0.01% of the Common Stock Deemed Outstanding, (c) the Replacement 2021 Warrant exercisable for an indeterminate number of shares of Common Stock equal to approximately 0.01% of the Common Stock Deemed Outstanding, (d) the Replacement 2022 Warrant exercisable for an indeterminate number of shares of Common Stock equal to approximately 0.01% of the Common Stock Deemed Outstanding, and (e) the 2023 Warrant exercisable for 1,636,313 shares of Common Stock. (2) The percentage reported in Row 13 is based on 32,791,280 shares of Common Stock outstanding as of July 31, 2026, as reported in the Issuer's quarterly report on Form 10-Q for the quarterly period ended June 30, 2026, filed with the SEC on August 3, 2026, plus 12,396 shares of Common Stock underlying the warrants referred to in clauses (b), (c) and (d) of footnote 1 above, plus 1,636,313 shares of Common Stock underlying the warrant referred to in clause (e) of footnote 1 above. Except with respect to the 2023 Warrant, the number of shares of Common Stock that will actually be issued upon exercise of the warrants described in this statement will not be known with certainty until the time such warrants are exercised. The number of shares of Common Stock actually issued upon exercise of such warrants may be materially different than the number of shares reflected in this statement.


SCHEDULE 13D


 
PACIFIC INVESTMENT MANAGEMENT CO LLC
 
Signature:/s/ Alyssa Creighton
Name/Title:Alyssa Creighton, Senior Vice President
Date:10/16/2026